Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3494719rdf:typepubmed:Citationlld:pubmed
pubmed-article:3494719lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C0053355lld:lifeskim
pubmed-article:3494719lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:3494719pubmed:issue3lld:pubmed
pubmed-article:3494719pubmed:dateCreated1987-6-19lld:pubmed
pubmed-article:3494719pubmed:abstractTextThe effect of ubenimex on the release of interleukin 1 (IL-1) and interleukin 2 (IL-2) from immuno-competent cells was studied. Ubenimex enhanced release of IL-1 from mouse peritoneal macrophages at 1.0 and 100 micrograms/ml in vitro and the release at 1.0 microgram/ml was larger. When ubenimex was administered to mice IL-1-releasing activity of the peritoneal macrophages was enhanced 3 and 5 days after the administration but not enhanced 1 day after the administration. Ubenimex also enhanced IL-2 release from rat spleen cells at 0.1 and 10 micrograms/ml, when concanavalin A (Con A) was added in the IL-2-releasing system. The enhancement was still observed with mouse spleen cells, when serum was further added. Moreover, thymocyte-proliferating activity was attained in the broths which rat spleen cells were incubated with ubenimex from 0.1 to 10 micrograms/ml in the absence and presence of Con A.lld:pubmed
pubmed-article:3494719pubmed:languageenglld:pubmed
pubmed-article:3494719pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3494719pubmed:citationSubsetIMlld:pubmed
pubmed-article:3494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3494719pubmed:statusMEDLINElld:pubmed
pubmed-article:3494719pubmed:monthMarlld:pubmed
pubmed-article:3494719pubmed:issn0021-8820lld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:TakahashiKKlld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:TakeuchiTTlld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:UmezawaHHlld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:HayashiEElld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:IshizukaMMlld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:AbeFFlld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:HorinishiHHlld:pubmed
pubmed-article:3494719pubmed:authorpubmed-author:ShibuyaKKlld:pubmed
pubmed-article:3494719pubmed:issnTypePrintlld:pubmed
pubmed-article:3494719pubmed:volume40lld:pubmed
pubmed-article:3494719pubmed:ownerNLMlld:pubmed
pubmed-article:3494719pubmed:authorsCompleteYlld:pubmed
pubmed-article:3494719pubmed:pagination363-9lld:pubmed
pubmed-article:3494719pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:meshHeadingpubmed-meshheading:3494719-...lld:pubmed
pubmed-article:3494719pubmed:year1987lld:pubmed
pubmed-article:3494719pubmed:articleTitleEnhancement of interleukin 1 and interleukin 2 releases by ubenimex.lld:pubmed
pubmed-article:3494719pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3494719lld:pubmed